# Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes

> **NCT00274274** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 373 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** insulin detemir
- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT00274274
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 373 (ACTUAL)
- **Last updated:** 2014-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00274274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00274274, "Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes". Retrieved via AI Analytics 2026-09-12 from https://api.ai-analytics.org/clinical/NCT00274274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*